Huons Global Co., Ltd. Logo

Huons Global Co., Ltd.

Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.

084110 | KO

Overview

Corporate Details

ISIN(s):
KR7084110006
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 9층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Huons Global Co., Ltd. is a holding company for a total healthcare group focused on providing solutions for human health. The company's core business encompasses the research, development, manufacturing, and sale of pharmaceutical products, medical devices, cosmetics, and health-functional food components. With a history dating back to 1965, the group has notable achievements, including the development of local anesthetics. Huons Global prioritizes expanding its research and development capabilities to find new growth engines and is actively advancing its presence in the global healthcare market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정(자회사의 주요경영사항)
Korean 6.3 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정(자회사의 주요경영사항) (중간배당)
Korean 9.6 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-07 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정(자회사의 주요경영사항)
Korean 14.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.7 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 10.5 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.8 MB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출(자회사의 주요경영사항)
Korean 26.8 KB
2025-03-14 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all Huons Global Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Huons Global Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Huons Global Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIOHARVEST SCIENCES INC. Logo
Biotech platform that grows plant cells to produce active compounds for human wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Clinical-stage biopharma developing drugs for neuroscience, immunology, and oncology.
United States of America
BHVN
BioInfra Co.,Ltd. Logo
Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.
South Korea
199730
BioInfra Life Science Inc. Logo
Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.
South Korea
266470
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel
BLRX
BIOMARIN PHARMACEUTICAL INC Logo
Develops and commercializes therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland
BMX
Biomea Fusion, Inc. Logo
Develops oral small molecules for metabolic diseases like diabetes and for specific cancers.
United States of America
BMEA
BIOMERICA INC Logo
Develops diagnostic tests for GI, inflammatory diseases, and diabetes for lab and at-home use.
United States of America
BMRA

Talk to a Data Expert

Have a question? We'll get back to you promptly.